Bachem Holding AG (BANB.SW) is in Healthcare, Biotechnology, based in Switzerland, listed on Swiss. Market cap 5.95B CHF. 52-week range 48.52 to 84.10 CHF. Trailing P/E 40.1. Data as of 2026-10-09.
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing ...